Accelerating the discovery of new cancer therapies using AI

Researchers at the UChicago Medicine Comprehensive Cancer Center and Argonne National Laboratory are partnering to use AI approaches to ...

Argonne, UChicago partner to accelerate discovery of new cancer ...

Researchers at the University of Chicago Medicine Comprehensive Cancer Center aim to explore ways to slow or stop the growth of tumors that ...

UChicagoCancerCenter on X: "A bold new project co-led by ...

A bold new project co-led by researchers at @UCCancerCenter and @Argonne aims to accelerate the discovery of new cancer therapies using AI.

The potential for AI to change cancer drug discovery and development

Our feature in the Rewriting Cancer digital series explores AI's potential to accelerate drug discovery and development in cancer care.

Accelerating Drug Discovery With AI for More Effective Treatments

Artificial intelligence (AI) can accelerate drug development, reduce costs, and improve treatment efficacy, but faces challenges like data ...

Cancer centers launch Cancer AI Alliance to unlock discoveries ...

“We are at a breakthrough moment for finding cancer cures thanks to rapid advancement in AI. With leading AI capabilities, diverse data types ...

Fusing Artificial Intelligence and Machine Learning for Anti-Cancer ...

These technologies enable scientists to overcome obstacles in the traditional drug development pipeline, accelerating the discovery and optimization of new anti ...

AI and Cancer - NCI

Accelerating cancer drug discovery. AI is being used in many ways to develop new treatments for cancer through novel approaches to drug ...

Harnessing AI to accelerate cancer drug development

Dr. Yasser Aldhamen is leveraging AI through a collaboration with Atomwise to develop novel immune-modulating drugs aimed at enhancing ...

Rewriting Cancer using AI - YouTube

Learn how we're helping our clients accelerate discovery and development of new cancer treatments using AI. ⬇ https://www.mckinsey.com ...

Initial in vivo validation of novel cancer therapeutics using AI

Overall, its integrated expertise in generative AI and tRNA-synthetase drug discovery has the potential to have a powerful impact on the ...

Review The emerging roles of artificial intelligence in cancer drug ...

AI could speed up the discovery of new materials, a move that could dramatically accelerate the development of anticancer drugs. It is believed that AI will be ...

4 Ways AI Is Accelerating Care Delivery Innovation | AHA

Drugmaker Pfizer is using AI and data to hasten drug discovery, manufacturing and the patient experience. AI technology, for instance, helped ...

Accelerating innovation to transform cancer care - AstraZeneca

We are using a multi-pronged approach – investing in genomics, data science and AI, next-generation sequencing and CRISPR gene editing – to ...

Using AI, USC researchers pioneer a potential new immunotherapy ...

A team of researchers from USC Norris Comprehensive Cancer Center built a machine learning system to identify genes that can convert brain cancer cells into ...

Using AI to Accelerate the Next Generation of Oncology ...

In this webinar: · What exactly AI can address in clinical efficiencies, drug discovery and drug development · How AI can illuminate the “dark matter” of the ...

Accelerating Therapy Discovery and Approval With AI - CGTLive®

The platform, in and of itself, enables us to make drugs very efficiently for common diseases and for rare disease indications. We're at a point ...

How AI can help cancer patients receive personalized and precise ...

Providence is working with Microsoft on prototype AI tools to improve care for cancer patients, accelerate progress in understanding cancer and ...

The Tech Revolutionizing Cancer Research and Care - NCI

CRISPR. Revolutionizing gene editing · Artificial Intelligence. Computer programming used to improve cancer diagnosis, drug development, and precision medicine.

Advances of Artificial Intelligence in Anti-Cancer Drug Design

After the identification of therapeutic targets for anti-cancer drugs, we need to screen for anti-cancer drug hit compounds, which are molecules with initial ...